BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2872829)

  • 1. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
    Ellison EC; O'Dorisio TM; Benson GD
    Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocrine-active gastrointestinal tumors: are there any new therapeutic possibilities?].
    Marbet UA; Kraenzlin M; Gyr K; Stalder GA
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1120-3. PubMed ID: 2426077
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.
    Hofeldt FD; Dippe SE; Levin SR; Karam JH; Blum MR; Forsham PH
    Diabetes; 1974 Mar; 23(3):192-8. PubMed ID: 4361409
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
    Osei K; O'Dorisio TM
    Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary endocrine-secreting pancreatic tumors.
    Macaron C
    Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
    Buck M; Kvols LK; O'Dorisio TM
    Am J Med; 1987 May; 82(5B):92-5. PubMed ID: 2884883
    [No Abstract]   [Full Text] [Related]  

  • 7. Octreotide--a synthetic somatostatin.
    Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
    Santangelo WC; Dueno MI; Krejs GJ
    Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
    Reubi JC; Heitz PU; Gyr K
    Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current views on endocrine neoplasms of the pancreas (review of the literature)].
    Georgiev Ch; Damianov D
    Khirurgiia (Mosk); 1985 Aug; (8):135-41. PubMed ID: 2997538
    [No Abstract]   [Full Text] [Related]  

  • 11. [The islet cell tumors of the pancreas (author's transl)].
    Ito Y; Fujimoto Y
    Horumon To Rinsho; 1981 Apr; 29(4):433-8. PubMed ID: 6271427
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumors of the endocrine pancreas.
    Friesen SR
    N Engl J Med; 1982 Mar; 306(10):580-90. PubMed ID: 6120456
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide: Jack-of-all-trades or expensive orphan?
    Offerhaus L
    Neth J Med; 1988 Jun; 32(5-6):265-9. PubMed ID: 2899297
    [No Abstract]   [Full Text] [Related]  

  • 14. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
    Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
    Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
    Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
    Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma.
    Curnow RT; Carey RM; Taylor A; Johanson A; Murad F
    N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin and analogues in the treatment of VIPoma.
    O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
    Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endocrine tumors of the pancreas].
    Aeberhard P; König MP
    Chirurg; 1983 Feb; 54(2):65-73. PubMed ID: 6133705
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic insulinoma with long survival and glucagonoma syndrome.
    D'Arcangues CM; Awoke S; Lawrence GD
    Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human pancreatic islet cells and their tumors. II. Ulcerogenic and diarrheogenic tumors.
    Greider MH; Rosai J; McGuigan JE
    Cancer; 1974 May; 33(5):1423-43. PubMed ID: 4132699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.